FindTrial
Sign In

The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.

A Pilot Study to Test the Effect of the Association of Epigallocatechin Gallate (EGCG), Folic Acid and Vitamin B12 in Preventing the Persistence of Human Papilloma Virus (HPV) Infection.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06285357
Enrollment
100
Registered
2024-02-29
Start date
2024-02-19
Completion date
2026-08-31
Last updated
2025-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV Infection

Brief summary

The purpose of the study is to test the effect of the administration of a dietary supplement consisting of epigallocatechin gallate (EGCG), vitamin B12 and folic acid in the treatment of infections with papilloma virus of the cervix.

Interventions

DIETARY_SUPPLEMENTEGCG + folic acid + B12

EGCG + folic acid + B12

Sponsors

Lo.Li.Pharma s.r.l
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* HR-HPV DNA test positivity

Exclusion criteria

* No HSIL

Design outcomes

Primary

MeasureTime frameDescription
HPV DNA test negativity8 months of treatmentPercentage

Countries

Italy

Contacts

Primary ContactGiovanni Grandi
giovanni.grandi@unimore.it+390594222830

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026